U.S. stocking partner for HoneyPower Lot HON-26/MY-5579 Two capsules a day · 60 per bottle 180-day money-back guarantee

HoneyPower Official Website › Side Effects

Side Effects

Is HoneyPower Safe? Side Effects and Interactions

HoneyPower's safety picture comes from its six ingredients, as no trial has tested the finished capsule.

Three of the four with an NIH liver safety review hold its mildest grade. Raise two interactions with your doctor first: ginseng with warfarin, and piperine with drugs cleared by CYP3A4.

Next, check the dose on how to take HoneyPower.

What is documented, what is an interaction, and what nobody has measured.

Written by the HoneyPower Team at MyhoneypowerMedical review: Dr. Shawn Blick, MDRevised

What the record holds

What is known about HoneyPower side effects?

Six plants, four formal safety assessments, and two interactions that matter.

No trial has ever been run on this finished capsule, so nobody holds a tolerability table for the product itself. What exists is a safety record for each of the six plants on the ingredient graphic, most of it built at doses far larger than two capsules can hold, and that record is unusually quiet.

Ginseng, maca and horny goat weed each carry a formal liver-injury assessment from the National Institutes of Health, and all three land on the same reassuring end of the scale. Honey is a food with centuries of use behind it. Black pepper extract appears in a fraction of a gram and is there for absorption rather than for an effect of its own.

That leaves two things worth a buyer’s attention, and both are interactions rather than side effects: ginseng against warfarin, and piperine against anything cleared by the liver enzyme it inhibits. Each is set out in full below, once, with the study that measured it.

The short version
  • Nobody has trialled the finished HoneyPower capsule, so there is no product-level side effect table and this desk does not print one.
  • Ginseng, maca and horny goat weed all hold NIH LiverTox likelihood score E, the grade meaning an unlikely cause of clinically apparent liver injury.
  • Ginseng plus warfarin is the one interaction here with a randomised trial behind it.
  • Piperine, the active in black pepper extract, inhibits CYP3A4 and P-glycoprotein.
  • Tribulus has a single published case of severe kidney injury in a young healthy man.
  • Honey is a bee product, so a bee or pollen sensitivity is a direct reason to skip it.
Ingredient by ingredient

The HoneyPower ingredients and what each one is documented to do

What the published safety literature holds for each of the six names.

IngredientFormal safety recordWhat a buyer should know
Pure HoneyA food, eaten in kilograms a year across the worldThe documented harms are regional grayanotoxin honeys at spoonful doses and infant botulism under one year of age. Neither reaches an adult swallowing a capsule. A bee product allergy is the real exclusion
Panax GinsengLiverTox likelihood score EThe most-reported effects across its trial literature are trouble sleeping and headache. It has one measured drug interaction, set out in the next section
Maca RootLiverTox likelihood score EA twelve-week randomised trial at three grams a day in 175 adults was run specifically to look at acceptability and safety, and reported no signal
Tribulus TerrestrisLiverTox likelihood score E-starThe star means an unproven but possible rare cause at high doses or in existing liver disease. One published case of severe kidney injury exists, in a young healthy man taking it deliberately
Horny Goat WeedLiverTox likelihood score EThe chapter records the usual commercial product as one 250 mg or 500 mg capsule a day, and notes the sexual-function effects are not proven in controlled trials
Black Pepper ExtractA kitchen spice in an extracted formPresent to change absorption. That mechanism is the reason it needs a section of its own rather than a line in a list

The liver scores are read off the NIH LiverTox chapters linked in the reference list, not recalled. Each chapter states its own grade on its first screen.

Four of the six have been assessed formally by a National Institutes of Health programme whose entire purpose is to find liver signals, and three of the four came back on the quiet end of the grade. The right-hand column is where a buyer should spend his attention: two entries there are about medicines rather than about plants, and they are the two things on this page that could change a decision.

The first interaction

HoneyPower and warfarin: the interaction with a trial behind it

One randomised trial, one direction of travel, and one conversation worth having.

Warfarin is dosed to a blood test. A man on it has an INR target, and anything that nudges the number moves him off it. Ginseng does nudge it, and that is not a theoretical worry drawn from a mechanism diagram.

A randomised, controlled trial in healthy volunteers gave American ginseng at one gram twice daily and measured warfarin’s effect falling. The finding was published in the Annals of Internal Medicine as a brief communication, which is where a result gets printed when it is small, clean and worth knowing quickly.

It is not the only record. A report in patients with replacement heart valves described the same direction of travel in people who were on warfarin for a reason nobody would want to get wrong. A wider systematic review of ginseng’s adverse effects and drug interactions collects the rest.

If you take warfarin or any other anticoagulant

Raise HoneyPower with whoever manages your INR before the first capsule, and name ginseng specifically. This is not a general caution dressed up as a specific one: there is a randomised trial, it used one gram twice daily, and the direction it measured was a reduction in warfarin’s effect.

What nobody can tell you is how much ginseng is in this bottle. The trial figure is two grams a day. A two-capsule serving has to carry six ingredients, so it is almost certainly a fraction of that. But “almost certainly a fraction” is an inference, and an inference is the wrong thing to hand a man on an anticoagulant.

The second interaction

Black pepper extract in HoneyPower and the medicines it can lift

What an absorption enhancer does, and why it cannot be selective.

Black pepper extract is on this panel for a reason that has nothing to do with male vitality. Its active, piperine, is an absorption enhancer: it is added to formulas so that whatever else is in them reaches the bloodstream in greater quantity.

The way it does that is the point. Piperine inhibits CYP3A4 and P-glycoprotein, two of the body’s main routes for clearing swallowed compounds. CYP3A4 alone handles a large share of prescription medicines. A review of herbal effects on P-glycoprotein sets out how broad that second route is.

An absorption enhancer cannot tell a nutrient from a tablet. The mechanism that lifts a botanical’s blood level lifts a medicine’s by the same means, which is why this ingredient earns a section rather than a bullet point.

The figure worth carrying away

The human study everyone cites used 20 mg of piperine, alongside two grams of curcumin, and measured the effect on curcumin. Nobody has measured piperine against honey, ginseng, maca, tribulus or icariin, and nobody has measured it inside HoneyPower.

None of that makes the ingredient a problem. It makes it a question to raise if your medicine list is long, and a reason to keep the two-capsule serving on the label rather than doubling it on a slow week.

Formal assessments

What the liver records say about the HoneyPower botanicals

Four NIH chapters, four grades, and the one case report that sits outside them.

LiverTox is a National Institutes of Health database that grades substances on how likely they are to cause clinically apparent liver injury. Its scale runs from A, where the link is well established, down to E, where it is not. Four of the six ingredients here have their own chapter.

Ginseng holds score E. Maca holds score E. Horny goat weed holds score E, and its chapter adds two useful sentences: the usual commercial product is one 250 mg or 500 mg capsule a day, and the sexual-function effects have not been proven in rigorous prospective controlled trials. Tribulus holds score E-star, the starred grade meaning unproven but possible at high doses or in someone whose liver is already compromised.

There is separate mechanistic work on Epimedium and the liver. A 2022 metabolomics study looked at how Epimedium koreanum might produce injury, in the laboratory rather than at a clinical rate.

The one outlier in the safety literature is not a liver signal at all. A case report describes severe kidney injury in a young healthy man taking tribulus. One case does not make a rate, and the amounts involved in a deliberate single-ingredient course are not the amounts a six-plant capsule can hold. It is recorded here because it is on the record and a reader is entitled to find it on this page rather than somewhere else.

Fair limits

How much is known about HoneyPower safety?

The section that says what the rest of the page cannot.

Everything above describes the plants. None of it describes the capsule, and the difference is worth stating plainly in the one section built for it.

Three specific gaps sit between the literature and this bottle. The first is quantity: the artwork names six ingredients and prints an amount for none of them, so no safety figure from any trial can be scaled to this serving. The second is combination: every study cited here tested one plant, and six together is a different experiment nobody has run. The third is sourcing: an extract’s strength depends on the plant part, the solvent and the standardisation, and none of those is stated either.

What the safety picture genuinely has going for it

  • Four of the six carry a formal NIH liver assessment, and three of those sit at the quiet end of the grade.
  • The two interactions that matter are both identified, both mechanistically understood, and both have published measurement behind them.
  • The serving is two capsules, which is a small, fixed, unambiguous amount of whatever the bottle holds.
  • The seller prints a 180-day refund window, so a man who does not get on with the capsule is not stuck with five more bottles.

What it cannot tell you

  • No trial of the finished product exists, so the tolerability of this specific combination is unmeasured.
  • Without amounts, nobody can say whether the ginseng in a serving is anywhere near the two grams a day the warfarin trial used.
  • The plant part and extract ratio are unstated for all six, and those change an extract’s strength several times over.
  • A buyer with a complicated medicine list has no figures to hand his prescriber, only names.

The practical consequence is specific. A healthy man with no prescriptions has very little here to weigh. A man on warfarin, or on a long list of tablets cleared by CYP3A4, has a real conversation to have first, with the ingredient names in his hand rather than a milligram figure somebody invented for him.

Exclusions

Who should not take HoneyPower

Seven lines, in the order a buyer is most likely to be caught by them.

  • Anyone under eighteen. The product is sold for adult men and the artwork says so.
  • Women who are pregnant or nursing. None of the work behind these six plants enrolled them, and the formula is not aimed at them.
  • Anyone on warfarin or another anticoagulant, until a prescriber has been asked about ginseng by name.
  • Anyone whose medicine list includes something cleared by CYP3A4, for the same reason piperine is on the panel at all.
  • Anyone with a bee or pollen allergy. Honey leads the ingredient graphic and gives the product its name.
  • Anyone with existing liver disease, because the one starred grade in the four chapters above attaches specifically to that situation.
  • Anyone who needs the milligram figure before deciding, because this artwork carries none and this desk will not supply one from elsewhere.

The bee product line catches people more often than the medication lines do. Honey is the first name on the graphic, it is in the brand name, and a man who avoids honey in his tea should not be buying it in a capsule.

Stopping points

When to stop taking HoneyPower

Five signals, four about safety and one about whether to continue.

Anything that looks like an allergic reaction

Swelling, hives, wheeze or a rash after a dose. Stop, and get it looked at the same day. Honey is a bee product and this is the reaction that will not wait.

Dark urine, pale stools or yellowing

The classic signals of liver trouble. The grades above make this unlikely rather than impossible, and unlikely is a reason to keep going normally, not a reason to ignore it if it happens.

A change in how a prescription medicine feels

The piperine question arriving in practice. If something you have taken for years starts behaving differently after you begin, stop the capsule and say so at the next appointment.

Sleep going backwards

Trouble sleeping is the effect reported most often across the ginseng trial literature. Moving the dose earlier in the day is the usual first answer; if it persists, the capsule is not worth the trade.

Nothing at all by week twelve

A decision point rather than a safety matter. Twelve weeks is the outer edge of the trials behind these plants and the 180-day window is still open.

Asked and answered

HoneyPower safety questions buyers ask

Does HoneyPower have side effects?
No trial of the finished capsule exists, so there is no product-level side effect table. Across the six ingredients, the most-reported effects in the published literature are trouble sleeping and headache, both from the ginseng trials. The two things worth real attention are interactions rather than side effects: ginseng with warfarin, and piperine with anything cleared by CYP3A4.
Can I take HoneyPower with blood pressure medication?
Ask first, and name black pepper extract when you do. Many blood pressure medicines are cleared by CYP3A4, which piperine inhibits, and the whole reason that ingredient is on the panel is to raise how much of something reaches the bloodstream. The answer may well be yes; it should be someone with your medicine list in front of them who says so.
Is HoneyPower safe for the liver?
Three of the four ingredients with an NIH LiverTox chapter hold likelihood score E, the grade meaning an unlikely cause of clinically apparent liver injury. Tribulus holds E-star, which adds a qualifier for high doses and for people with existing liver disease. Nobody has assessed the six together, because nobody has studied the six together.
I am allergic to bee stings. Can I take HoneyPower?
Not without asking. Honey is the first ingredient on the seller’s own graphic and it is in the product’s name. A bee venom allergy and a honey allergy are not the same thing, but they sit close enough together that this is a question for someone who knows your history rather than for a website.
Does HoneyPower interact with erectile dysfunction medication?
Nobody has tested the combination. The mechanistic worry is icariin, the compound in horny goat weed, which inhibits PDE5 in a test tube — the same enzyme those medicines target. That work was done in glassware and in cultured cells, never in people, so it is a reason to mention the capsule at the appointment rather than a documented interaction.
Sources and sign-off

Sources behind the HoneyPower safety record

The trials, case reports and NIH chapters named on this page.

  1. Yuan and colleagues, 2004 (Ann Intern Med): a randomized, controlled trial in healthy volunteers in which American ginseng at 1 g twice a day weakened the effect of warfarin. PubMed record 15238367
  2. Lee and colleagues, 2010 (Int J Cardiol): an interaction between warfarin and Korean red ginseng reported in patients with replacement heart valves. PubMed record 19913311
  3. Coon and Ernst, 2002 (Drug Saf): a systematic review of Panax ginseng’s side effects and drug interactions. PubMed record 12020172
  4. LiverTox (NIDDK), ginseng chapter, updated 14 March 2018: likelihood score E, meaning ginseng on its own is an unlikely cause of clinically apparent liver injury. NCBI Bookshelf NBK548200
  5. LiverTox (NIDDK), maca chapter, updated 10 April 2019: likelihood score E, an unlikely cause of clinically apparent liver injury. NCBI Bookshelf NBK548552
  6. Gonzales-Arimborgo and colleagues, 2016 (Pharmaceuticals): a randomized, double-blind, placebo-controlled study in adults taking black or red maca extract at 3 g a day for 12 weeks, judged on acceptability, safety and effect. PubMed record 27548190
  7. LiverTox (NIDDK), tribulus chapter, updated 8 August 2022: likelihood score E-star, an unproven but possible rare cause of clinically apparent liver injury at high doses or in people who already have liver disease. NCBI Bookshelf NBK583201
  8. Talasaz and colleagues, 2010 (Nephrol Dial Transplant): a case report of severe kidney damage linked to tribulus in a young man who had been healthy. PubMed record 20667992
  9. LiverTox (NIDDK), horny goat weed chapter, updated 8 August 2022: likelihood score E, an unlikely cause of clinically apparent liver injury. The chapter puts the usual product at one 250 mg or 500 mg capsule a day and says its sexual-function effects have not been proven in rigorous prospective controlled trials. NCBI Bookshelf NBK583203
  10. Li and colleagues, 2022 (Front Pharmacol): a metabolomics study of how Epimedium koreanum can injure the liver. PubMed record 35910368
  11. Dell’Agli and colleagues, 2008 (J Nat Prod): laboratory work in which icariin derivatives blocked the human PDE5 enzyme in vitro, with no people involved. PubMed record 18778098
  12. Shoba and colleagues, 1998 (Planta Med): curcumin absorption with and without piperine in animals and human volunteers; in people, 20 mg of piperine taken with 2 g of curcumin raised curcumin’s blood level. The effect was measured on curcumin, not on honey, ginseng, maca, tribulus or icariin. PubMed record 9619120
  13. Bhardwaj and colleagues, 2002 (J Pharmacol Exp Ther): piperine from black pepper blocked the human drug transporter P-glycoprotein and the CYP3A4 enzyme. The mechanism that raises a nutrient’s blood level can raise a medicine’s as well. PubMed record 12130727
  14. Zhou, Lim and Chowbay, 2004 (Drug Metab Rev): a review of how herbal products act on P-glycoprotein. PubMed record 15072439
  15. Jansen and colleagues, 2012 (Cardiovasc Toxicol): a review of grayanotoxin poisoning, the condition known as mad honey disease. PubMed record 22528814
  16. Gunduz and colleagues, 2008 (Clin Toxicol): a clinical review of mad honey (grayanotoxin) poisoning over the years. PubMed record 18568799
  17. Harris, Anniballi and Austin, 2024 (Curr Microbiol): a review of infant botulism and where Clostridium botulinum spores are found. PubMed record 39138824
  18. NCCIH, part of the NIH: the consumer fact sheet on Asian ginseng, what it is used for and how safe it is. nccih.nih.gov fact sheet
  19. NCCIH, part of the NIH: consumer advice on choosing supplements with care and telling every health care provider what you take. nccih.nih.gov guidance
A single HoneyPower bottle, front label, 60 capsules

Read the HoneyPower interactions before the first capsule, not after

Two capsules a day, 60 to a bottle, and 180 days from purchase to change your mind if it does not suit you.

One bottle $69 · six bottles $294 · 180-day money-back guarantee

Order HoneyPower On The Official Website

Two capsules a day · 60 per bottle · lot HON-26/MY-5579

180-day money-back guarantee

Six months to make up your mind, longer than any study of these six botanicals lasted

The seller’s window runs 180 days from the purchase date and covers empty bottles too. To claim it, contact the order desk listed in the footer with your order ID, then work through the refund policy steps.

Order HoneyPower On The Official Website

Lot HON-26/MY-5579 · from $49 a bottle · read the guarantee first

The HoneyPower six-bottle pack, front labels showing
HoneyPower · two capsules a day $49 a bottle on the six-pack · 180-day money-back guarantee
Add To Cart